Results 31 to 40 of about 69,189 (50)

Cotton flower metabolites inhibit SARS‐CoV‐2 main protease

open access: yesFEBS Open Bio, 2022
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has been spreading globally for over 2 years, causing serious contagious disease and incalculable damage.
Yufang Zhang   +9 more
doaj   +1 more source

Whole genome sequencing of recombinant viruses obtained from co-infection and superinfection of Vero cells with modified vaccinia virus ankara vectored influenza vaccine and a naturally occurring cowpox virus

open access: yesFrontiers in Immunology
Modified vaccinia virus Ankara (MVA) has been widely tested in clinical trials as recombinant vector vaccine against infectious diseases and cancers in humans and animals.
Diana Diaz-Cánova   +4 more
doaj   +1 more source

Orbital inflammatory disease following mRNA SARS‐CoV‐2 vaccine

open access: yesClinical Case Reports, 2022
A 65‐year‐old woman reported orbital symptoms two days after her first dose and presented exacerbation of signs after the second dose of BNT162b2 mRNA vaccine.
Solange Grunenwald   +4 more
doaj   +1 more source

Follow-up SARS-CoV-2 serological study of a health care worker cohort following COVID-19 booster vaccination

open access: yesBMC Infectious Diseases
Background Studies have shown that Omicron breakthrough infections can occur at higher SARS-CoV-2 antibody levels compared to previous variants. Estimating the magnitude of immunological protection induced from COVID-19 vaccination and previous infection
Alexander Hönning   +11 more
doaj   +1 more source

Tear antibodies to SARS‐CoV‐2: implications for transmission

open access: yesClinical & Translational Immunology, 2021
Objectives SARS‐CoV‐2 can be transmitted by aerosols, and the ocular surface may be an important route of transmission. Little is known about protective antibody responses to SARS‐CoV‐2 in tears after infection or vaccination.
Kevin J Selva   +10 more
doaj   +1 more source

SARS‐CoV‐2 RNA screening in routine pathology specimens

open access: yesMicrobial Biotechnology, 2021
Summary Virus detection methods are important to cope with the SARS‐CoV‐2 pandemics. Apart from the lung, SARS‐CoV‐2 was detected in multiple organs in severe cases.
Saskia vonStillfried   +14 more
doaj   +1 more source

17β‐estradiol reduces SARS‐CoV‐2 infection in vitro

open access: yesPhysiological Reports, 2021
The COVID‐19 has originated from Wuhan, China, in December 2019 and has been affecting the public health system, society, and economy in an unheard‐of manner. There is no specific treatment or vaccine available for COVID‐19. Previous data showed that men
Robertha Mariana Rodrigues Lemes   +15 more
doaj   +1 more source

Infección por SARS-COV-2 en trabajadores de la salud: análisis de riesgo epidemiológico en una institución de alta complejidad de Bogotá, Colombia, 2020

open access: yesInfectio, 2022
Objective: To determine the incidence of SARS-CoV-2 infection and its association with sociodemographic, clinical, and occupational characteristics in health workers (HCWs) in the COVID-19 risk area.Material and method: Longitudinal analytical study in a
Milcíades Ibáñez-Pinilla
doaj   +1 more source

Animal models for SARS‐CoV‐2 infection and pathology

open access: yesMedComm, 2021
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is the etiology of coronavirus disease 2019 (COVID‐19) pandemic. Current variants including Alpha, Beta, Gamma, Delta, and Lambda increase the capacity of infection and transmission of SARS‐CoV‐
Zhenfei Bi   +4 more
doaj   +1 more source

Collaborated effort against SARS‐CoV‐2 outbreak in China

open access: yesClinical and Translational Medicine, 2020
A previously unknown beta coronavirus, SARS‐CoV‐2, was discovered from a cluster of patients with pneumonia of unknown cause in Wuhan since the end of 2019.
Qiwen Yang   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy